Posted by Michael Wonder on 22 May 2021
US biotech Novavax could make COVID vaccine onshore in Australia
20 May 2021 - American biotechnology company Novavax has outlined plans to make doses of its coronavirus vaccine in Australia after revealing it is searching for a manufacturing partner to produce its protein-based jab onshore.
The federal government has ordered 51 million doses of Novavax’s product, which is still awaiting regulatory clearances in the US and Australia.
In an interview with The Sydney Morning Herald and The Age, Novavax’s chief commercial officer John Trizzino said the company has had early conversations with potential manufacturing partners to produce doses locally, for Australians and to export across the Asia-Pacific region.
